2020
DOI: 10.1055/s-0040-1719153
|View full text |Cite
|
Sign up to set email alerts
|

Benefit of Self-Managed Anticoagulation in Patients with Left Ventricular Assist Device

Abstract: Background The exact monitoring of the therapeutic-range international normalized ratio (INR) after left ventricular assist device (LVAD) implantation is an important aim to reduce the risk of thrombosis or bleeding complications. Service providers offer a telemedical anticoagulation service (CS). Methods We compared LVAD patients using the CS (n = 15) to those who received regular medical care (RMC; n = 15) to investigate if telemedicine supervision increased the INR-specific time in the therapeutic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 22 publications
(30 reference statements)
0
4
0
Order By: Relevance
“…Additionally, a higher heterogeneity is usually expected in meta-analyses of continuous outcomes [ 46 ]. Different baseline TTRs also could have influenced the impact of the intervention, as it is expected that populations with lower baseline TTRs derive a larger benefit from any intervention that promotes a better quality of therapy [ 7 , 34 - 36 ]. Even in recent clinical trials of DOAC versus warfarin, TTR in control groups varied widely across various geographical regions [ 47 ], reaching values as low as 36% in India.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Additionally, a higher heterogeneity is usually expected in meta-analyses of continuous outcomes [ 46 ]. Different baseline TTRs also could have influenced the impact of the intervention, as it is expected that populations with lower baseline TTRs derive a larger benefit from any intervention that promotes a better quality of therapy [ 7 , 34 - 36 ]. Even in recent clinical trials of DOAC versus warfarin, TTR in control groups varied widely across various geographical regions [ 47 ], reaching values as low as 36% in India.…”
Section: Discussionmentioning
confidence: 99%
“…The 25 studies included 3 cluster randomized controlled trials [17][18][19] and 22 individually randomized parallel-group trials [7][8][9][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38], totaling 25,746 patients. One study held 2 independent comparisons based on different INR target ranges, so these distinct pairs of comparisons are represented as "Vadher a" and "Vadher b" in some analyses [22].…”
Section: Studies and Patients' Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, a higher heterogeneity is usually expected in meta-analyses of continuous outcomes [46]. Different baseline TTRs also could have influenced the impact of the intervention, as it is expected that populations with lower baseline TTRs derive a larger benefit from any intervention that promotes a better quality of therapy [7,[34][35][36]. Even in recent clinical trials of DOAC versus warfarin, TTR in control groups varied widely across various geographical regions [47], reaching values as low as 36% in India.…”
Section: Principal Findingsmentioning
confidence: 99%